Antidepressant-like activity of turmerone in behavioral despair tests in mice

BMC Complementary and Alternative Medicine

Wen-Huang Peng⁴  Lung-Yuan Wu²  Hui-Chi Huang⁴  Chia-Yu Liu¹  Jen-Chieh Tsai⁵  Jung-Chun Liao³ 

[1] Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, No. 79-9, Sha-Luen-Hu, Xi Zhou Li, Hou-Loung Town, Miaoli County 35664, Taiwan;School of Chinese Medicine for Post Baccalaureate, I-Shou university, No.1, Sec. 1, Syuecheng Rd., Dashu District, Kaohsiung City 84001, Taiwan;School of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan;Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, No. 91, Hsueh-Shih Road, Taichung 404, Taiwan;Department of Health and Nutrition Biotechnology, College of Health Science, Asia University, Taichung 404, Taiwan

关键词: Monoamines;    Antidepressant;    Tail suspension test;    Forced swimming test;    Tumerone;   

Others  :  1220831
DOI  :  10.1186/1472-6882-13-299

 received in 2013-08-07, accepted in 2013-10-29,  发布年份 2013

【 摘 要 】

Background

The present study was undertaken to evaluate the anti-depressive activity of turmerone after one-week administration by using a mouse forced swimming test (FST) and tail suspension test (TST).

Methods

Animals were divided into four groups (n = 10 /group): control (0.9% saline), the three doses of turmerone (1.25, 2.5, 5.0 mg/kg) for one-week treatment. To assess the effect of turmerone on locomotor activity, mice were evaluated in the open-field paradigm. Forced swimming test (FST) and Tail suspension test (TST) were used to take as a measure of antidepressant activity. The probable mechanisms of action of the anti-depressive effect of turmerone was also investigated by measuring the activity of monoamine oxidase-A and corticosterone levels in the blood and the levels of monoamines in the cortex, striatum, hippocampus and hypothalamus of the mice.

Results

Turmerone (2.5, 5.0 mg/kg, p.o.) significantly reduced the immobility time of mice in both the FST and TST, but it did not significantly affect the ambulatory and total movements of mice. However, hyperactivity might explain the results. In addition, turmerone decreased the corticosterone level in the blood while it increased the levels of 5-HT in cortex, striatum, hippocampus, and hypothalamus, the level of NE in striatum and hippocampus, the levels of MHPG and DOPAC in hypothalamus, the level of 5-HIAA in striatum, and the level of DA in striatum, hippocampus, and hypothalamus. Turmerone (2.5, 5.0 mg/kg) decreased the activity of MAO-A in the frontal cortex and hippocampus of mouse brain.

Conclusions

After one-week administration, turmerone produced antidepressant-like effects. The mechanisms of action of anti-depressive effect of turmerone seemed to involve an increase of the monoamines level decreasing the MAO-A activity and the stress of mice.

【 授权许可】

   
2013 Liao et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 3.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y: Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1417-1424.
• [2]Yi LT, Xu HL, Feng J, Zhan X, Zhou LP, Cui CC: Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol Behav 2011, 102:1-6.
• [3]Delgado PL: Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61:7-11.
• [4]Chuang CY, Shi YC, You HP, Lo YH, Pan TM: Antidepressant effect of GABA-rich monascus-fermented product on forced swimming rat model. J Agric Food Chem 2011, 59:3027-3034.
• [5]Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53:649-659.
• [6]Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, Jacinto J, Veronezi PO, Pizzolatti MG, Rodrigues AL: Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidencefor the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:335-343.
• [7]Bertoli A, Giovannini A, Ruffoni B, Guardo AD, Spinelli G, Mazzetti M, Pistelli L: Bioactive constituent production in St. John’s Wort in vitro hairy roots. Regenerated plant lines. J Agric Food Chem 2008, 56:5078-5082.
• [8]Yu ZF, Kong LD, Chen Y: Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 2002, 83:161-165.
• [9]Kumar A, Chomwal R, Kumar P, Sawal R: Anti-inflammatory and wound healing activity of Curcuma aromatica salisb extract and its formulation. J Chem Pharm Res 2009, 1:304-310.
• [10]Al-Reza SM, Rahman A, Sattar MA, Rahman MO, Fida HM: Essential oil composition and antioxidant activities of Curcuma aromatica Salisb. Food Chem Toxicol 2010, 48:1757-1760.
• [11]Choochote W, Chaiyasit D, Kanjanapothi D, Rattanachanpichai E, Jitpakdi A, Tuetun B, Pitasawat B: Chemical composition and anti-mosquito potential of rhizome extract and volatile oil derived from Curcuma aromatica against Aedes aegypti (Diptera: Culicidae). J Vector Ecol 2005, 30:302-309.
• [12]Wu WY, Xu Q, Shi LC, Zhang WB: Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice. World J Gastroenterol 2000, 6:216-219.
• [13]Lee YL, Weng CC, Mau JL: Antioxidant properties of ethanolic and hot water extracts from the rhizome of curcuma aromatic. J Food Biochem 2007, 31:757-771.
• [14]Micó JA, Ardid D, Berrocoso E, Eschalier A: Antidepressants and pain. Trends Pharmacol Sci 2006, 27:348-354.
• [15]Krell HV, Leuchter AF, Cook IA, Abrams M: Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 2005, 46:379-384.
• [16]Kulkarni SK, Bhutani MK, Bishnoi M: Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 2008, 201:435-442.
• [17]Bhutani MK, Bishnoi M, Kulkarni SK: Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 2009, 92:39-43.
• [18]Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ: Antidepressant effects of curcumin in the forced swimming test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 2005, 82:200-206.
• [19]Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB: Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28:1765-1773.
• [20]Cryan JF, Markou A, Lucki I: Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
• [21]Porsolt RD, Bertin A, Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
• [22]Zomkowski AD, Santos AR, Rodrigues AL: Involvement of opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 2005, 381:279-283.
• [23]Zhou D, Jin H, Lin HB, Yang XM, Cheng YF, Deng FJ, Xu JP: Antidepressant effect of the extracts from Fructus Akebiae. Pharmacol Biochem Behav 2010, 94:488-495.
• [24]Steru L, Chermat R, Thierry B, Simon P: The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
• [25]Rodrigues AL, Rocha JB, Mello CF, Souza DO: Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. Pharmacol Toxicol 1996, 79:150-156.
• [26]Renard CE, Dailly E, David DJ, Hascot M, Bourin M: Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 2003, 17:449-455.
• [27]Schurr A, Livne A: Different inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem Pharmacol 1976, 25:1201-1203.
• [28]Lowry OH, Rosebrough NJ, Far AL, Randall R: Protein measurement with folin phenol reagent. J Biol Chem 1951, 193:265-275.
• [29]Buchenauer T, Behrendt P, Bode FJ, Horn R, Brabant G, Stephan M, Nave H: Diet-induced obesity alters behavior as well as serum levels of corticosterone in F344 rats. Physiol Behav 2009, 98:563-569.
• [30]Porsolt RD, Bertin A, Jalfre M: Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 1978, 51:291-294.
• [31]Borsini F, Meli A: Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 1998, 94:147-160.
• [32]Li S, Wang C, Li W, Koike K, Nikaido T, Wang MW: Antidepressant-like effects of piperine and its derivative, antiepilepsirine. J Asian Nat Prod Res 2007, 9:421-430.
• [33]Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li G, Pan J, Ogle WO: Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 2010, 20:405-413.
• [34]Shiflett MW, Balleine BW: Contributions of ERK signaling in the striatum to instrumental learning and performance. Behav Brain Res 2011, 218:240-247.
• [35]Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O: Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007, 38:247-252.
• [36]Szafarczyk A, Ixart G, Gaillet S, Siaud P, Barbanel G, Malaval F, Assenmacher I: Stress. Neurophysiologic studies. Encéphale 1993, 1:137-142.
• [37]Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Friedman JH: The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisollevels in endogenous depression. Psychoneuroendocrinology 1987, 12:295-301.
• [38]Ayensu WK, Pucilowski O, Mason GA, Overstreet DH, Rezvani AH, Janowsky DS: Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in flinders lines of rats. Physiol Behav 1995, 57:165-169.
• [39]Drossopoulou G, Antoniou K, Kitraki E, Papathanasiou G, Papalexi E, Dalla C, Papadopoulou-Daifoti Z: Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 2004, 126:849-857.